002370 亚太药业
已收盘 04-29 15:00:00
资讯
新帖
简况
股市必读：亚太药业年报 - 第四季度单季净利润同比下降102.35%
证券之星 · 04-27
股市必读：亚太药业年报 - 第四季度单季净利润同比下降102.35%
亚太药业最新公告：一季度净亏损258.75万元
证券之星 · 04-24
亚太药业最新公告：一季度净亏损258.75万元
亚太药业（002370）披露关于变更签字注册会计师的公告，4月15日股价上涨4.3%
证券之星 · 04-15
亚太药业（002370）披露关于变更签字注册会计师的公告，4月15日股价上涨4.3%
亚太药业：公司不参加上述会议
证券之星 · 04-14
亚太药业：公司不参加上述会议
沪指V型反弹，福建本地股爆发，平潭发展4天2板，铝概念掀涨停潮
21世纪经济报道 · 03-30
沪指V型反弹，福建本地股爆发，平潭发展4天2板，铝概念掀涨停潮
亚太药业（002370）披露关于增加2026年度日常关联交易预计额度的议案，3月25日股价上涨2.44%
证券之星 · 03-25
亚太药业（002370）披露关于增加2026年度日常关联交易预计额度的议案，3月25日股价上涨2.44%
股市必读：亚太药业（002370）3月23日收盘跌5.52%，主力净流出1881.91万元
证券之星 · 03-24
股市必读：亚太药业（002370）3月23日收盘跌5.52%，主力净流出1881.91万元
亚太药业（002370）披露对外投资设立子公司公告，3月4日股价上涨0.31%
证券之星 · 03-04
亚太药业（002370）披露对外投资设立子公司公告，3月4日股价上涨0.31%
亚太药业(002370.SZ)子公司拟参设亚钛星浩 完善业务链条
智通财经 · 03-04
亚太药业(002370.SZ)子公司拟参设亚钛星浩 完善业务链条
亚太药业在浙江成立控股新公司
财闻 · 03-03
亚太药业在浙江成立控股新公司
亚太药业（002370）披露全资子公司完成工商登记公告，3月2日股价下跌3.78%
证券之星 · 03-02
亚太药业（002370）披露全资子公司完成工商登记公告，3月2日股价下跌3.78%
亚太药业：公司预计2025年度营业收入3.5亿元-3.7亿元
证券之星 · 02-05
亚太药业：公司预计2025年度营业收入3.5亿元-3.7亿元
股市必读：亚太药业（002370）预计2025年全年营业收入3.5亿元至3.7亿元
证券之星 · 02-02
股市必读：亚太药业（002370）预计2025年全年营业收入3.5亿元至3.7亿元
亚太药业（002370）披露2025年度业绩预告，1月30日股价上涨0.28%
证券之星 · 01-30
亚太药业（002370）披露2025年度业绩预告，1月30日股价上涨0.28%
股市必读：亚太药业（002370）1月27日收盘跌5.22%，主力净流出1388.9万元
证券之星 · 01-28
股市必读：亚太药业（002370）1月27日收盘跌5.22%，主力净流出1388.9万元
亚太药业（002370）披露召开2026年第一次临时股东大会通知，1月23日股价上涨0.67%
证券之星 · 01-23
亚太药业（002370）披露召开2026年第一次临时股东大会通知，1月23日股价上涨0.67%
亚太药业：股份转让获深交所合规确认
证券之星 · 2025-12-18
亚太药业：股份转让获深交所合规确认
亚太药业（002370）披露拟变更会计师事务所及多项制度修订公告，12月8日股价上涨2.31%
证券之星 · 2025-12-08
亚太药业（002370）披露拟变更会计师事务所及多项制度修订公告，12月8日股价上涨2.31%
亚太药业：优化产品结构拓展海外市场
证券之星 · 2025-12-05
亚太药业：优化产品结构拓展海外市场
股市必读：亚太药业（002370）11月18日收盘跌6.19%，主力净流出2501.85万元
证券之星 · 2025-11-19
股市必读：亚太药业（002370）11月18日收盘跌6.19%，主力净流出2501.85万元
加载更多
公司概况
公司名称：
浙江亚太药业股份有限公司
所属行业：
医药制造业
上市日期：
2010-03-16
主营业务：
浙江亚太药业股份有限公司的主营业务是化学制剂的研发、生产和销售。公司的主要产品是抗生素类制剂、非抗生素类制剂、服务。
发行价格：
16.00
{"stockData":{"symbol":"002370","market":"SZ","secType":"STK","nameCN":"亚太药业","latestPrice":6.62,"timestamp":1777446180000,"preClose":6.62,"halted":0,"volume":20327002,"delay":0,"changeRate":0,"floatShares":746000000,"shares":746000000,"eps":0.1362,"marketStatus":"已收盘","change":0,"latestTime":"04-29 15:00:00","open":6.6,"high":6.7,"low":6.49,"amount":135000000,"amplitude":0.0317,"askPrice":6.63,"askSize":177,"bidPrice":6.62,"bidSize":3059,"shortable":0,"etf":0,"ttmEps":0.1362,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1777512600000},"marketStatusCode":5,"adr":0,"adjPreClose":6.62,"symbolType":"stock","openAndCloseTimeList":[[1777426200000,1777433400000],[1777438800000,1777446000000]],"highLimit":7.28,"lowLimit":5.96,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":745667530,"isCdr":false,"pbRate":4.42,"roa":"--","peRate":48.604993,"roe":"--","epsLYR":0.13,"committee":0.115043,"marketValue":4936000000,"turnoverRate":0.0273,"status":2,"floatMarketCap":4936000000},"requestUrl":"/m/hq/s/002370","defaultTab":"news","newsList":[{"id":"2630133518","title":"股市必读：亚太药业年报 - 第四季度单季净利润同比下降102.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630133518","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630133518?lang=zh_cn&edition=full","pubTime":"2026-04-27 02:02","pubTimestamp":1777226538,"startTime":"0","endTime":"0","summary":"截至2026年4月24日收盘，亚太药业报收于6.96元，上涨1.75%，换手率4.66%，成交量34.74万手，成交额2.4亿元。股本股东变化股东户数变动近日亚太药业披露，截至2026年3月31日公司股东户数为8.81万户，较12月31日增加9495.0户，增幅为12.08%。董事会关于独立董事2025年度独立性自查情况的专项意见浙江亚太药业股份有限公司董事会根据相关法规要求，对公司2025年度在任独立董事吕海洲、刘岳辉、蔡敏的独立性情况进行评估。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700004857.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002370"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629825550","title":"亚太药业最新公告：一季度净亏损258.75万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2629825550","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629825550?lang=zh_cn&edition=full","pubTime":"2026-04-24 23:40","pubTimestamp":1777045212,"startTime":"0","endTime":"0","summary":"亚太药业(002370.SZ)公告称，2026年第一季度实现营业收入5957.63万元，同比下降7.71%；归属于上市公司股东的净利润亏损258.75万元。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042400067789.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002370","BK0132","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627076644","title":"亚太药业（002370）披露关于变更签字注册会计师的公告，4月15日股价上涨4.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2627076644","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627076644?lang=zh_cn&edition=full","pubTime":"2026-04-15 17:05","pubTimestamp":1776243954,"startTime":"0","endTime":"0","summary":"截至2026年4月15日收盘，亚太药业报收于7.52元，较前一交易日上涨4.3%，最新总市值为56.07亿元。该股当日开盘7.33元，最高7.53元，最低7.08元，成交额达7.99亿元，换手率为14.55%。漏玉燕自2014年9月成为注册会计师，近三年签署上市公司审计报告超过2家次，曾于2025年4月因武汉天喻信息产业股份有限公司2023年年报审计项目部分审计程序不到位被湖北证监局出具警示函。本次变更不会对公司2025年度审计工作产生不利影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041500030402.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002370","BK0132","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627955467","title":"亚太药业：公司不参加上述会议","url":"https://stock-news.laohu8.com/highlight/detail?id=2627955467","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627955467?lang=zh_cn&edition=full","pubTime":"2026-04-14 08:46","pubTimestamp":1776127569,"startTime":"0","endTime":"0","summary":"证券之星消息，亚太药业(002370)04月13日在投资者关系平台上答复投资者关心的问题。投资者提问：你好，董秘，请问一下就是贵公司是否会参加今年的AACR会议的召开？亚太药业回复：您好，感谢您对公司的关注！公司不参加上述会议。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041400006242.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0132","002370"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623398628","title":"沪指V型反弹，福建本地股爆发，平潭发展4天2板，铝概念掀涨停潮","url":"https://stock-news.laohu8.com/highlight/detail?id=2623398628","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623398628?lang=zh_cn&edition=full","pubTime":"2026-03-30 11:49","pubTimestamp":1774842540,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 记者|黎雨桐 见习记者林芊蔚。 3月30日，A股早盘探底回升，沪指拉升翻红，此前一度跌超1%，创业板指、深成指跌幅明显收窄。 福建本地股异动拉升，平潭发展4天2板，海峡创新涨超10%，厦门港务、路桥信息、漳州发展、福建金森、东百集团、福建水泥跟涨。航天军工股集体拉升，广联航空涨超10%，航天南湖涨超6%。投资者据此操作，风险自担。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/marketresearch/2026-03-30/doc-inhsttra9801068.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/marketresearch/2026-03-30/doc-inhsttra9801068.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0077","000300.SH","512880","BK0140","000592","000905.SH","002370","515890","600547","BK4535","BK0188","BK0230","BK0070","399006","000688.SH","510880","BK0012","01787","002160","BK0054","BK0096","399001","510300","BK0106","159967","BK0028","512510"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622721440","title":"亚太药业（002370）披露关于增加2026年度日常关联交易预计额度的议案，3月25日股价上涨2.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622721440","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622721440?lang=zh_cn&edition=full","pubTime":"2026-03-25 22:31","pubTimestamp":1774449070,"startTime":"0","endTime":"0","summary":"截至2026年3月25日收盘，亚太药业报收于6.29元，较前一交易日上涨2.44%，最新总市值为46.9亿元。该股当日开盘6.13元，最高6.31元，最低6.13元，成交额达9676.35万元，换手率为2.07%。近日，浙江亚太药业股份有限公司发布《关于召开2026年第二次临时股东会的通知》。股权登记日为2026年4月7日。会议将审议《关于增加2026年度日常关联交易预计额度的议案》。会议登记时间为2026年4月8日，可通过现场、信函、电子邮件或传真方式登记。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032500044364.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0239","002370"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621083070","title":"股市必读：亚太药业（002370）3月23日收盘跌5.52%，主力净流出1881.91万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2621083070","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621083070?lang=zh_cn&edition=full","pubTime":"2026-03-24 01:44","pubTimestamp":1774287857,"startTime":"0","endTime":"0","summary":"截至2026年3月23日收盘，亚太药业报收于5.82元，下跌5.52%，换手率3.09%，成交量23.07万手，成交额1.37亿元。当日关注点来自交易信息汇总：亚太药业股价连续3日下跌，3月23日收盘报5.82元，跌5.52%。前10个交易日资金流向情况：主力资金累计净流出9409.17万元，股价累计下跌12.49%；融资余额累计减少767.58万元，融券余量累计增加0股。资金流向3月23日主力资金净流出1881.91万元；游资资金净流出150.96万元；散户资金净流入2032.87万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400001675.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002370","BK0132","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616556209","title":"亚太药业（002370）披露对外投资设立子公司公告，3月4日股价上涨0.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616556209","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616556209?lang=zh_cn&edition=full","pubTime":"2026-03-04 22:26","pubTimestamp":1772634379,"startTime":"0","endTime":"0","summary":"截至2026年3月4日收盘，亚太药业报收于6.49元，较前一交易日上涨0.31%，最新总市值为48.39亿元。该股当日开盘6.45元，最高6.57元，最低6.39元，成交额达8861.47万元，换手率为1.83%。近日，亚太药业披露《关于对外投资设立子公司的公告》。公告显示，公司全资子公司浙江雅泰利众控股有限公司与海南泰泽丰医药科技有限公司于2026年3月4日签订《投资合作协议》，拟共同出资设立浙江亚钛星浩药业有限公司。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030400040285.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002370","BK0132","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616535336","title":"亚太药业(002370.SZ)子公司拟参设亚钛星浩 完善业务链条","url":"https://stock-news.laohu8.com/highlight/detail?id=2616535336","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616535336?lang=zh_cn&edition=full","pubTime":"2026-03-04 17:29","pubTimestamp":1772616565,"startTime":"0","endTime":"0","summary":"智通财经APP讯，亚太药业(002370.SZ)公告，公司全资子公司雅泰利众于2026年3月4日与泰泽丰医药签订《投资合作协议》，双方拟共同出资设立浙江亚钛星浩药业有限公司(暂定名，简称“亚钛星浩”)，亚钛星浩注册资本1000万元，其中雅泰利众出资600万元，占注册资本的60%，泰泽丰医药出资400万元，占注册资本的40%。据悉，实施该事项有利于进一步完善公司在医药领域的业务链条，提升产业协同效应与综合竞争实力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1409982.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0132","BK0239","002370"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616239070","title":"亚太药业在浙江成立控股新公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2616239070","media":"财闻","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616239070?lang=zh_cn&edition=full","pubTime":"2026-03-03 13:25","pubTimestamp":1772515500,"startTime":"0","endTime":"0","summary":"企查查APP显示，近日，浙江雅泰利众控股有限公司成立，注册资本5000万元，经营范围包含：控股公司服务；以自有资金从事投资活动；自有资金投资的资产管理服务等。企查查股权穿透显示，该公 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20260303/c675039714.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["002370","BK0132","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616355817","title":"亚太药业（002370）披露全资子公司完成工商登记公告，3月2日股价下跌3.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616355817","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616355817?lang=zh_cn&edition=full","pubTime":"2026-03-02 22:30","pubTimestamp":1772461842,"startTime":"0","endTime":"0","summary":"截至2026年3月2日收盘，亚太药业报收于6.62元，较前一交易日下跌3.78%，最新总市值为49.36亿元。近日，浙江亚太药业股份有限公司发布公告称，公司拟以自有资金5,000.00万元设立全资子公司浙江雅泰利众投资控股有限公司。该子公司已完成工商登记手续，并取得绍兴市越城区市场监督管理局颁发的营业执照。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030200039864.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0132","002370"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609701003","title":"亚太药业：公司预计2025年度营业收入3.5亿元-3.7亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2609701003","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609701003?lang=zh_cn&edition=full","pubTime":"2026-02-05 20:51","pubTimestamp":1770295895,"startTime":"0","endTime":"0","summary":"证券之星消息，亚太药业02月04日在投资者关系平台上答复投资者关心的问题。根据《深圳证券交易所股票上市规则》相关规定，最近一个会计年度经审计的利润总额、净利润、扣除非经常性损益后的净利润三者孰低为负值，且扣除后的营业收入低于3亿元，深交所对其股票交易实施退市风险警示。根据公司于2026年1月31日披露的《2025年度业绩预告》，公司预计2025年度营业收入3.5亿元-3.7亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020500037632.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002370"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608889594","title":"股市必读：亚太药业（002370）预计2025年全年营业收入3.5亿元至3.7亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608889594","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608889594?lang=zh_cn&edition=full","pubTime":"2026-02-02 03:15","pubTimestamp":1769973313,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘，亚太药业报收于7.11元，上涨0.28%，换手率2.13%，成交量15.89万手，成交额1.13亿元。亚太药业发布业绩预告，预计2025年全年营业收入3.5亿元至3.7亿元。公司公告汇总2025年度业绩预告浙江亚太药业股份有限公司预计2025年度归属于上市公司股东的净利润为10,000万元至12,000万元，同比增长192.06%至250.47%。公司已于2025年12月26日支付部分款项98.53万元，2026年1月9日支付剩余款项517.59万元，并申请解除冻结。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200001526.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002370"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607904496","title":"亚太药业（002370）披露2025年度业绩预告，1月30日股价上涨0.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607904496","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607904496?lang=zh_cn&edition=full","pubTime":"2026-01-30 22:57","pubTimestamp":1769785031,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘，亚太药业报收于7.11元，较前一交易日上涨0.28%，最新总市值为53.02亿元。该股当日开盘7.08元，最高7.19元，最低7.03元，成交额达1.13亿元，换手率为2.13%。近日，浙江亚太药业股份有限公司披露《2025年度业绩预告》。公告显示，公司预计2025年度归属于上市公司股东的净利润为10,000万元至12,000万元，同比增长192.06%至250.47%；扣除非经常性损益后的净利润为亏损4,200万元至6,000万元，同比下降49.30%至113.28%；营业收入预计为35,000万元至37,000万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026013000047803.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0239","002370"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606317157","title":"股市必读：亚太药业（002370）1月27日收盘跌5.22%，主力净流出1388.9万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606317157","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606317157?lang=zh_cn&edition=full","pubTime":"2026-01-28 01:45","pubTimestamp":1769535914,"startTime":"0","endTime":"0","summary":"截至2026年1月27日收盘，亚太药业报收于7.45元，下跌5.22%，换手率9.43%，成交量70.33万手，成交额5.22亿元。当日关注点来自交易信息汇总：1月27日亚太药业收盘报7.45元，跌5.22%，主力资金当日净流出1388.9万元。前10个交易日资金流向情况：主力资金累计净流出3608.04万元，股价累计下跌1.28%；融资余额累计减少2737.42万元，融券余量累计增加0股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012800001079.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0132","002370"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605406836","title":"亚太药业（002370）披露召开2026年第一次临时股东大会通知，1月23日股价上涨0.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605406836","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605406836?lang=zh_cn&edition=full","pubTime":"2026-01-23 22:29","pubTimestamp":1769178556,"startTime":"0","endTime":"0","summary":"截至2026年1月23日收盘，亚太药业报收于7.5元，较前一交易日上涨0.67%，最新总市值为55.93亿元。近日，浙江亚太药业股份有限公司发布《关于召开2026年第一次临时股东会的通知》。会议审议事项包括选举第八届董事会5名非独立董事和3名独立董事，以及修订《公司章程》的议案。《公司章程》修订属于特别决议事项，须经出席股东会的股东所持有效表决权的2/3以上通过。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012300043190.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","002370","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2592261269","title":"亚太药业：股份转让获深交所合规确认","url":"https://stock-news.laohu8.com/highlight/detail?id=2592261269","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592261269?lang=zh_cn&edition=full","pubTime":"2025-12-18 11:36","pubTimestamp":1766028972,"startTime":"0","endTime":"0","summary":"2025年12月8日，公司收到深圳证券交易所下发的《深圳证券交易所上市公司股份协议转让确认书》，深圳证券交易所已完成对本次股份协议转让相关材料的合规确认，确认书有效期为六个月，转让双方需按照确认书载明的转受让股份数量一次性办理过户登记。本次股份转让事项尚需在中国证券登记结算公司深圳分公司办理股份过户登记手续。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121800012785.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","002370","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2589305359","title":"亚太药业（002370）披露拟变更会计师事务所及多项制度修订公告，12月8日股价上涨2.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2589305359","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589305359?lang=zh_cn&edition=full","pubTime":"2025-12-08 22:19","pubTimestamp":1765203578,"startTime":"0","endTime":"0","summary":"截至2025年12月8日收盘，亚太药业报收于7.53元，较前一交易日上涨2.31%，最新总市值为56.15亿元。该股当日开盘7.4元，最高7.67元，最低7.4元，成交额达4.03亿元，换手率为7.19%。近日，浙江亚太药业股份有限公司发布公告称，公司将于2025年12月24日召开2025年第三次临时股东大会，会议由董事会召集，现场会议时间为当日14:00，网络投票时间为9:15至15:00。股权登记日为2025年12月18日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120800034891.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002370","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2589851238","title":"亚太药业：优化产品结构拓展海外市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2589851238","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589851238?lang=zh_cn&edition=full","pubTime":"2025-12-05 09:24","pubTimestamp":1764897856,"startTime":"0","endTime":"0","summary":"证券之星消息，亚太药业12月04日在投资者关系平台上答复投资者关心的问题。公司目前正积极应对市场环境变化，通过优化产品结构，拓展营销渠道，探索新营销模式和海外市场的开发，加大费用管控，降本增效，努力提升盈利能力，以期实现公司的持续、稳定、健康发展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120500005733.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002370","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2584895952","title":"股市必读：亚太药业（002370）11月18日收盘跌6.19%，主力净流出2501.85万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584895952","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584895952?lang=zh_cn&edition=full","pubTime":"2025-11-19 01:00","pubTimestamp":1763485254,"startTime":"0","endTime":"0","summary":"截至2025年11月18日收盘，亚太药业报收于8.34元，下跌6.19%，换手率15.01%，成交量111.91万手，成交额9.44亿元。交易信息汇总股价提醒11月18日亚太药业收盘报8.34元，跌6.19%，当日成交1.12亿元。前10个交易日资金流向情况：主力资金累计净流出3.82亿元，股价累计下跌7.86%；融资余额累计增加1.15亿元，融券余量累计增加0股。资金流向11月18日主力资金净流出5240.31万元；游资资金净流入543.98万元；散户资金净流入4696.33万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111900000623.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0132","002370"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1777487992847,"stockEarnings":[{"period":"1week","weight":-0.0728},{"period":"1month","weight":-0.078},{"period":"3month","weight":-0.0663},{"period":"6month","weight":-0.1652},{"period":"1year","weight":1.0432},{"period":"ytd","weight":-0.0944}],"compareEarnings":[{"period":"1week","weight":0.0003},{"period":"1month","weight":0.047},{"period":"3month","weight":-0.0121},{"period":"6month","weight":0.0386},{"period":"1year","weight":0.2498},{"period":"ytd","weight":0.0349}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"浙江亚太药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"88101人(较上一季度增加12.08%)","perCapita":"8463股","listingDate":"2010-03-16","address":"浙江省绍兴市柯桥区群贤路2003号1501室","registeredCapital":"74566万元","survey":" 浙江亚太药业股份有限公司的主营业务是化学制剂的研发、生产和销售。公司的主要产品是抗生素类制剂、非抗生素类制剂、服务。","listedPrice":16},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"亚太药业(002370)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供亚太药业(002370)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"亚太药业,002370,亚太药业股票,亚太药业股票老虎,亚太药业股票老虎国际,亚太药业行情,亚太药业股票行情,亚太药业股价,亚太药业股市,亚太药业股票价格,亚太药业股票交易,亚太药业股票购买,亚太药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"亚太药业(002370)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供亚太药业(002370)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}